Clin2
NCT07772856Possibly a fitNot yet recruiting

Relaxing potassium limits for hemodialysis patients

End Stage Kidney Disease (ESKD)HemodialysisDiet InterventionHyperkalemiaPotassium Bioavailability

Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether relaxing the usual potassium restrictions in your diet is safe and helpful for people on hemodialysis. It may allow you to eat more foods you enjoy while keeping your potassium at a safe level.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
148 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old
  • You have been on maintenance hemodialysis for more than 3 months
  • You have had at least one high potassium level (over 5.0) in the past year
  • You are able to give consent
  • You do not take potassium-binding medications
  • You have good dialysis adequacy and attend regularly (no frequent misses)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07494266Recruiting
Potassium in plant-based diet for kidney patients

This trial tests whether a plant-based diet with more potassium is safe for people with advanced chronic kidney disease (CKD) compared to a plant-based diet with less potassium. It may help you understand how to manage your potassium levels while eating more plants.

Huddinge, Stockholm Län
NCT06940414Recruiting
Study of high potassium in kidney disease patients in community

This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.

Shanghai, Shanghai Municipality
NCT06256991Recruiting· Phase 4
Potassium management for kidney health

This study tests if careful potassium management can help people with chronic kidney disease (CKD) safely take higher doses of blood pressure medicines called ACE inhibitors or ARBs, which are known to protect the kidneys. You may be eligible if you have moderate to advanced CKD and are already on a moderate dose of one of these medications.

Groningen
NCT06736184Not yet recruiting· Phase 4
Heart protection by managing potassium levels during dialysis

This trial tests whether closely managing potassium levels during hemodialysis can help protect the heart in patients with kidney failure who are on maintenance dialysis. It aims to reduce the risk of heart problems related to potassium swings.

NCT06635590Recruiting
Kidney disease, high potassium, and heart changes

This study looks at how high potassium levels (hyperkalemia) in people with chronic kidney disease may affect the heart. Doctors will use echocardiograms (heart ultrasounds) to check for changes.

Ankara
NCT06724991Enrolling by invitation
Lower vs standard insulin dose for high potassium in ER

This study compares a lower dose versus a standard dose of insulin and dextrose (sugar water) to treat moderately high potassium levels in emergency department patients. It aims to see if a lower dose works just as well with fewer side effects.

Kuala Lumpur

Hear when a new Hemodialysis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.